sofwave treatment loose skin arms glp-1 How Bridges the Gap for the Generation Managing Skin Laxity During GLP-1

Insurance coverage for GLP-1 medications varies by plan and carrier

Roundhill Investments' GLP-1 & Weight Loss ETF (OZEM), which began trading last week, pairs leaders Eli Lilly and Novo Nordisk with players developing new treatments for weight loss and diabetes

GLP-1 Medications and Muscle Loss: What to Know About Nutrition and Supplements Apr 7, 2026 Medications such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) are changing how obesity and metabolic disease are treated

Obesity is a major risk factor for many chronic conditions like type 2 diabetes and cardiovascular diseases

We will typically see healthy weight loss averages anywhere between 10-25 pounds (about 5-10% of body weight) in 3 months time

These arent well studied, and I advise against them, says Rao